Roche launches comprehensive genomic profiling kit to expand access to personalized cancer research
The AVENIO Tumor Tissue Comprehensive Genomic Profiling Kit is the first jointly-developed product that brings together the expertise and reach of Roche with Foundation Medicine’s pioneering leadership in genomic science